吗啡及其他阿片类药物用于癌症疼痛治疗：欧洲姑息治疗学会（EAPC）的建议
Morphine and alternative opioids in cancer pain: the EAPC recommendations.
作者信息
Hanks G W, Conno F, Cherny N, Hanna M, Kalso E, McQuay H J, Mercadante S, Meynadier J, Poulain P, Ripamonti C, Radbruch L, Casas J R, Sawe J, Twycross R G, Ventafridda V
机构信息
Palliative Medicine, University of Bristol, Bristol Haematology and Oncology Centre, UK.
出版信息
Br J Cancer. 2001 Mar 2;84(5):587-93. doi: 10.1054/bjoc.2001.1680.
Abstract
An expert working group of the European Association for Palliative Care has revised and updated its guidelines on the use of morphine in the management of cancer pain. The revised recommendations presented here give guidance on the use of morphine and the alternative strong opioid analgesics which have been introduced in many parts of the world in recent years. Practical strategies for dealing with difficult situations are described presenting a consensus view where supporting evidence is lacking. The strength of the evidence on which each recommendation is based is indicated.
摘要
欧洲姑息治疗协会的一个专家工作组修订并更新了其关于吗啡在癌症疼痛管理中应用的指南。此处呈现的修订建议为吗啡以及近年来在世界许多地区引入的其他强效阿片类镇痛药的使用提供了指导。文中描述了应对困难情况的实用策略，并在缺乏支持证据的情况下给出了共识性观点。同时指出了每项建议所依据证据的力度。
相似文献
1
Morphine and alternative opioids in cancer pain: the EAPC recommendations.吗啡及其他阿片类药物用于癌症疼痛治疗：欧洲姑息治疗学会（EAPC）的建议
Br J Cancer. 2001 Mar 2;84(5):587-93. doi: 10.1054/bjoc.2001.1680.
2
[Morphine and alternative opioids in cancer pain: the EAPC recommendations].[吗啡及其他阿片类药物用于癌症疼痛治疗：欧洲姑息治疗学会（EAPC）推荐意见]
Schmerz. 2002 Jun;16(3):186-93. doi: 10.1007/s004820100104.
3
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).阿片类药物与老年人慢性重度疼痛的管理：一个国际专家小组的共识声明，重点关注世界卫生组织第三阶梯临床最常用的六种阿片类药物（丁丙诺啡、芬太尼、氢吗啡酮、美沙酮、吗啡、羟考酮）。
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
4
[Nociceptive cancer pain in adult patients: statement about guidelines related to the use of antinociceptive medicine].[成年患者的伤害感受性癌痛：关于使用抗伤害感受性药物的指南声明]
Ann Fr Anesth Reanim. 2007 Jun;26(6):502-15. doi: 10.1016/j.annfar.2007.03.029. Epub 2007 Jun 8.
5
Opioid switch in palliative care, opioid choice by clinical need and opioid availability.姑息治疗中的阿片类药物转换、根据临床需求选择阿片类药物以及阿片类药物的可及性。
Eur J Pain. 2005 Oct;9(5):571-9. doi: 10.1016/j.ejpain.2004.12.003. Epub 2005 Jan 20.
6
[Use of opioids against severe cancer pain].[阿片类药物用于治疗重度癌痛]
Tidsskr Nor Laegeforen. 2004 Feb 5;124(3):337-8.
7
Opioid therapy for chronic painful conditions.用于慢性疼痛病症的阿片类药物疗法。
Med Health R I. 2001 Oct;84(10):323-6.
8
Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.癌症疼痛患者的阿片类药物轮换。美沙酮、氢吗啡酮和吗啡之间剂量比的回顾性比较。
Cancer. 1996 Aug 15;78(4):852-7. doi: 10.1002/(SICI)1097-0142(19960815)78:4<852::AID-CNCR23>3.0.CO;2-T.
9
Morphine and hydromorphone-induced hyperalgesia in a hospice patient.吗啡和氢吗啡酮致 Hospice 患者痛觉过敏。
J Palliat Med. 2013 Jul;16(7):809-12. doi: 10.1089/jpm.2011.0502. Epub 2012 Aug 27.
10
引用本文的文献
1
Profiling Postpartum Recovery After Scheduled Cesarean Delivery With Neuraxial Anesthesia: A Longitudinal Cohort Study.硬膜外麻醉下行择期剖宫产术后的产后恢复情况剖析：一项纵向队列研究
Anesth Analg. 2025 Apr 4. doi: 10.1213/ANE.0000000000007476.
2
Reflecting on Cancer Pain as Constant Acute Pain, not Chronic Pain. 'Known Knowns, Known Unknowns, Unknown Unknowns'.将癌症疼痛视为持续性急性疼痛而非慢性疼痛。“已知的已知、已知的未知、未知的未知”。
Curr Oncol Rep. 2025 May;27(5):584-600. doi: 10.1007/s11912-025-01642-w. Epub 2025 Apr 3.
3
Opioid Utilisation in Hungary: National and Regional Analysis in Ambulatory and Hospital Care Sector.匈牙利的阿片类药物使用情况：门诊和医院护理部门的全国及区域分析
J Clin Med. 2025 Jan 29;14(3):897. doi: 10.3390/jcm14030897.
4
Incidence of Delirium during the Initiation Phase of Morphine and Hydromorphone Therapy in Cancer Patients: A Retrospective Comparative Study.癌症患者吗啡和氢吗啡酮治疗起始阶段谵妄的发生率：一项回顾性比较研究。
Can J Hosp Pharm. 2025 Jan 15;78(1):e3515. doi: 10.4212/cjhp.3515. eCollection 2025.
5
Do CYP2D6 genotypes affect oxycodone dose, pharmacokinetics, pain, and adverse effects in cancer?细胞色素P450 2D6（CYP2D6）基因分型是否会影响癌症患者的羟考酮剂量、药代动力学、疼痛及不良反应？
Pharmacogenomics. 2024;25(14-15):579-586. doi: 10.1080/14622416.2024.2430161. Epub 2024 Dec 4.
6
Intrathecal drug delivery for the management of pain and spasticity in adults: British Pain Society's recommendations for best clinical practice.鞘内给药用于成人疼痛和痉挛的管理：英国疼痛学会最佳临床实践建议
Br J Pain. 2024 Sep 7:20494637241280356. doi: 10.1177/20494637241280356.
7
Complication avoidance, rehabilitation, pain therapy and palliative care for patients with metastatic spine tumors: WFNS spine committee recommendations.转移脊柱肿瘤患者的并发症预防、康复、疼痛治疗和姑息治疗：WFNS 脊柱委员会建议。
Neurosurg Rev. 2024 Oct 30;47(1):830. doi: 10.1007/s10143-024-03050-3.
8
A real-world study of the quality of Outpatient Pain Management in patients with Cancer.一项针对癌症患者门诊疼痛管理质量的真实世界研究。
J Cancer Surviv. 2024 May 25. doi: 10.1007/s11764-024-01621-3.
9
Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital.在一家三级癌症医院的住院环境中，计划使用阿片类药物和突破性阿片类药物治疗癌症疼痛。
Curr Oncol. 2024 Mar 5;31(3):1335-1347. doi: 10.3390/curroncol31030101.
10
Palliative Care in Drug Resistance Tuberculosis: An Overlooked Component in Management.耐药结核病的姑息治疗：管理中被忽视的环节。
Indian J Palliat Care. 2023 Oct-Dec;29(4):388-393. doi: 10.25259/IJPC_141_2022. Epub 2023 Nov 11.
本文引用的文献
1
Opioids in pain management.疼痛管理中的阿片类药物。
Lancet. 1999 Jun 26;353(9171):2229-32. doi: 10.1016/S0140-6736(99)03528-X.
2
Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home.接受居家后续护理的晚期癌症患者的疼痛治疗及治疗效果。
Cancer. 1999 Apr 15;85(8):1849-58. doi: 10.1002/(sici)1097-0142(19990415)85:8<1849::aid-cncr27>3.0.co;2-6.
3
Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study.口服黏膜用枸橼酸芬太尼（OTFC）治疗癌症患者爆发性疼痛：一项剂量对照滴定研究。
Pain. 1999 Feb;79(2-3):303-12. doi: 10.1016/s0304-3959(98)00179-1.
4
Problems of long-term spinal opioid treatment in advanced cancer patients.晚期癌症患者长期脊柱阿片类药物治疗的问题。
Pain. 1999 Jan;79(1):1-13. doi: 10.1016/S0304-3959(98)00118-3.
5
Peak plasma concentrations after oral morphine: a systematic review.口服吗啡后的血浆峰浓度：一项系统评价。
J Pain Symptom Manage. 1998 Dec;16(6):388-402. doi: 10.1016/s0885-3924(98)00094-3.
6
Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.比较口服控释羟考酮与控释吗啡治疗癌痛患者安全性和有效性的随机、双盲、交叉试验。
J Clin Oncol. 1998 Oct;16(10):3222-9. doi: 10.1200/JCO.1998.16.10.3222.
7
Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?在癌症疼痛治疗中从吗啡转换为口服美沙酮：等效镇痛剂量比是多少？
J Clin Oncol. 1998 Oct;16(10):3216-21. doi: 10.1200/JCO.1998.16.10.3216.
8
Comparison of the analgesic and intestinal effects of fentanyl and morphine in rats.芬太尼与吗啡对大鼠镇痛及肠道作用的比较。
J Pain Symptom Manage. 1998 Apr;15(4):253-7. doi: 10.1016/s0885-3924(97)00371-0.
9
Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain.与每12小时服用一次美施康定相比，每24小时服用一次卡马西平治疗重度癌痛的药代动力学和药效学研究。
Pain. 1997 Feb;69(3):295-302. doi: 10.1016/S0304-3959(96)03269-1.
10
Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients.196例晚期癌症患者口服美沙酮治疗疼痛的临床经验。
J Clin Oncol. 1996 Oct;14(10):2836-42. doi: 10.1200/JCO.1996.14.10.2836.
Zotero 插件